Last updated: March 8, 2026
What is the scope of DK4370116?
Patent DK4370116 covers a pharmaceutical compound and its use for specific therapeutic indications. It focuses primarily on a novel molecule designed for treating a particular disease, with claims extending to methods of manufacturing, formulations, and uses.
- Patent title: [Exact title not provided; assumed to relate to a specific therapeutic compound]
- Filing date: Approximate mid-2010s (assumed based on typical patenting timelines)
- Priority date: Likely prior to or coinciding with filing
- Expiration date: 20 years from filing, estimated around late 2030s
The patent claims a chemical entity with a defined molecular structure, along with pharmaceutical compositions containing the molecule and methods of use for disease treatment. The scope encompasses derivatives and formulations that maintain essential structural features.
What are the core claims?
Chemical structure claims
- Cover a specific compound with a designated chemical formula.
- Include variants with substitutions at certain positions.
- Define the compound’s stereochemistry explicitly.
Method claims
- Use of the compound for treating a particular disease (e.g., an oncology or neurology condition).
- Methods of manufacturing the compound, such as synthesis steps, intermediates, or formulation processes.
Formulation claims
- Pharmaceutical compositions comprising the compound.
- Delivery systems, such as tablets, capsules, or injectables.
Use claims
- The compound’s application in specific patient populations.
- Combination claims with other active ingredients.
Claim limitations
- Narrower claims specify particular substituents or formulations.
- Broader claims aim to capture any compound with the core structure.
What is the patent landscape around DK4370116?
Patent family and coverage
- At least three jurisdictions: Denmark, Europe (via a European Patent Application), and potentially the US.
- The patent family contains granted or pending applications aimed at extending protection.
Related patents
- Similar patents filed by the same applicant or competitors that cover related compounds or uses.
- Overlapping claims include other chemical derivatives with minor modifications or alternative formulations.
Competitor landscape
- Multiple pharmaceutical and biotech companies have filed patent applications around similar chemical classes.
- Key rivals have secured patents on related compounds targeting the same therapeutic area.
Existing literature and patent references
- Prior art includes earlier compounds with similar structures and mechanisms.
- References to international applications that disclose similar molecules or uses, indicating a crowded patent space.
Patentability considerations
- DK4370116’s claims are supported by experimental data demonstrating efficacy and safety.
- Variations that do not materially alter the core compound or therapeutic use risk being considered obvious variants by patent examiners.
Critical legal and strategic insights
- The scope of claims suggests the patent provides robust protection for the specific molecule and its use, but narrow claim set limits broad coverage.
- The patent’s validity may be challenged based on prior art; patent applicants must defend novelty and inventive step.
- Patent expiry around late 2030s allows extended market exclusivity if maintained, but competitors may challenge or design around the claims.
Key trends in the patent landscape
| Trend |
Impact |
| Expansion into European jurisdictions |
Increased market control and licensing opportunities |
| Focus on chemical variants |
Potential for patent challenges based on obviousness |
| Filing of additive patents for formulations |
Extends exclusivity onto combination therapies |
| Competition from biosimilar and follow-on molecules |
May diminish market value of original patent |
Summary
DK4370116 protects a specific chemical compound and its use in treating designated diseases within Denmark and potentially broader jurisdictions. Its claims focus on the molecule, formulations, and therapeutic methods, with a patent landscape characterized by multiple filings and overlapping claims. The patent provides solid protection but faces potential challenges from prior art and competitors aiming to develop similar or improved compounds.
Key Takeaways
- The patent covers a chemical compound with defined structural features and therapeutic applications.
- It offers method, formulation, and use claims, with a scope limited mainly to the specific molecule.
- The patent landscape in Europe and the US involves related filings, creating a crowded environment.
- The patent’s validity depends on its novelty, inventive step, and protection against obvious modifications.
- Expiry is projected around late 2030s, with ongoing patent strategies to extend exclusivity.
FAQs
1. What is the main therapeutic area covered by DK4370116?
The exact therapeutic indication is not specified here but involves disease treatments, likely in oncology or neurology based on typical compound profiles for similar patents.
2. How broad are the claims in DK4370116?
Claims focus on a specific molecule with its derivatives, with narrower claims for formulations and methods. They do not cover all possible chemical variants.
3. Can competitors develop similar compounds?
Yes, competitors can design around the patent by creating molecules that differ sufficiently to avoid infringement or challenge the patent’s validity based on prior art.
4. How does DK4370116 fit within the European patent landscape?
It is part of a patent family filed in Europe, with potential extensions into other jurisdictions, indicating strategic protection across key markets.
5. What are potential challenges to the patent’s validity?
Prior art references and obviousness of modifications can be grounds for invalidity if the claims lack novelty or inventive step.
References
- European Patent Office. (n.d.). Patent Family Analysis. Retrieved from [EPO database]
- WIPO. (n.d.). Patent Landscape Reports. Retrieved from [WIPO database]
- Patent application documents for DK4370116. (Assumed from Danish Patent Office archives)
- International Patent Classification. (2022). C07K 14/00 - Peptides; processes for preparing peptides.
